Care pathways & referral

Cancer Treatment Is an Endurance Event. Stop Waiting for Patients to Lose Function.

When the Test Says Normal but the Pain Does Not

Triglycerides are back in the spotlight. Europe is reviewing Sobi’s olezarsen for severe risk.

Germany Is Paying the Price for Leaving Tardive Dyskinesia Behind

Before a TB Vaccine Exists, Africa Is Building the Route to People

Europe’s next stroke bet: can Factor XIa inhibition change prevention without raising bleeding risk?

MASH, a serious fatty liver disease, is becoming a cardiometabolic condition

ESC Cardio-Oncology 2026: Cancer therapy is getting smarter. Cardiac protection is still playing catch-up.

ENDO 2026 reveals the GLP-1 revolution’s real challenge: delivery
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
